1 study on Epac mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research suggests a novel therapeutic strategy for hypertension and hyperaldosteronism by combining a GLP-1R agonist with a PDE4 inhibitor. Combining liraglutide with roflumilast could offer enhanced cardiovascul…